#Medicaid

The results of a poll in seven states “are alarming and should hasten our…efforts on viral suppression.” There’s also good news!

Having health insurance increases early detection and timely treatment for many cancers.

A better understanding of Medicare and Medicaid

The Trump administration had proposed changing which meds were covered, including HIV and cancer drugs.

The proposal rolls back nondiscrimination policies of the Affordable Care Act, notably for transgender people and women who had abortions.

Insurance companies can no longer implement harmful co-pay accumulator policies.

A look at the supply chain that results in very high costs for HIV and hepatitis C medications.

Nearly 21 million Americans could lose coverage. Meanwhile, the GOP won’t offer a health care replacement until after 2020.

In fact, antiviral drugs account for nearly 14 percent of total drug costs in the program.

The patient advocacy coalition I Am Essential sent a letter to the HHS spelling out why the plan is dangerous.

Can loads more research dollars stop Alzheimer’s disease by 2025?

A national survey gauges HIV care providers’ views about the Affordable Care Act.

Medi-Cal will soon begin providing treatment access to almost all state-insured patients living with the virus.

The denial rate, which is higher for the privately insured than those with Medicaid or Medicare, is on the rise.

Stocks of drug companies are rising—and that’s not a good sign for consumers.

A new analysis broke down U.S. PrEP use by location and demographics and compared it with corresponding HIV diagnosis rates.